Article
Insights into the binding recognition and computational design of IL-2 muteins with enhanced predicted binding affinity to the IL-2 receptor α.
Journal of molecular graphics & modelling - 1 Dec 2024
Charoenwongpaiboon Thanapon, Klaewkla Methus
Abstract excerpt
Interleukin-2 (IL-2) is an immune system regulator that has received approval for cancer treatment. However, high-dose IL-2 therapy has seen restricted use due to its low efficacy and on-target toxicity. To enhance the effectiveness of IL-2 therapy, it is essential to engineer IL-2 molecules to enhance their specificity toward target cell populations. In this study, molecular dynamics (MD) simulations and Rosetta...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
